BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 6864687)

  • 1. D-penicillamine treatment of progressive systemic sclerosis (scleroderma): a comparison of clinical and in vitro effects.
    Shapiro LS; Prince RK; Buckingham RB; Rodnan GP
    J Rheumatol; 1983 Apr; 10(2):316-8. PubMed ID: 6864687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progressive systemic sclerosis (PSS, scleroderma) dermal fibroblasts synthesize increased amounts of glycosaminoglycan.
    Buckingham RB; Prince RK; Rodnan GP
    J Lab Clin Med; 1983 May; 101(5):659-69. PubMed ID: 6833837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progressive systemic sclerosis and penicillamine.
    Rodnan GP
    J Rheumatol Suppl; 1981; 7():116-20. PubMed ID: 6939873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A 15-year prospective study of treatment of rapidly progressive systemic sclerosis with D-penicillamine [see comment].
    Jimenez SA; Sigal SH
    J Rheumatol; 1991 Oct; 18(10):1496-503. PubMed ID: 1765974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of systemic sclerosis with extracorporeal photochemotherapy. Results of a multicenter trial.
    Rook AH; Freundlich B; Jegasothy BV; Perez MI; Barr WG; Jimenez SA; Rietschel RL; Wintroub B; Kahaleh MB; Varga J
    Arch Dermatol; 1992 Mar; 128(3):337-46. PubMed ID: 1550365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Penicillamine therapy in systemic sclerosis.
    Jayson MI; Lovell C; Black CM; Wilson RS
    Proc R Soc Med; 1977; 70 Suppl 3(Suppl 3):82-8. PubMed ID: 122683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of interleukin-4 in scleroderma skin specimens and scleroderma fibroblast cultures. Potential role in fibrosis.
    Salmon-Ehr V; Serpier H; Nawrocki B; Gillery P; Clavel C; Kalis B; Birembaut P; Maquart FX
    Arch Dermatol; 1996 Jul; 132(7):802-6. PubMed ID: 8678573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of dermal connective tissue in scleroderma.
    Kähäri VM
    Ann Med; 1993 Dec; 25(6):511-8. PubMed ID: 8292298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of generalized scleroderma with inhibitors of connective tissue formation.
    Asboe-Hansen G
    Acta Derm Venereol; 1975; 55(6):461-5. PubMed ID: 55038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of imatinib (Glivec) on scleroderma and normal dermal fibroblasts: a preclinical study.
    Soria A; Cario-André M; Lepreux S; Rezvani HR; Pasquet JM; Pain C; Schaeverbeke T; Mahon FX; Taïeb A
    Dermatology; 2008; 216(2):109-17. PubMed ID: 18216472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Systemic sclerosis].
    Gustafsson R
    Nord Med; 1994; 109(8-9):236-7. PubMed ID: 7937033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of progressive scleroderma with D-penicillamine (Metalcaptase)].
    Böni A; Pavelka K; Kludas M
    Munch Med Wochenschr; 1969 Aug; 111(31):1580-4. PubMed ID: 5394493
    [No Abstract]   [Full Text] [Related]  

  • 13. [Experience using d-penicillamine in systemic scleroderma].
    Nemchinov EN; Krel' AA; Shekhter AB; Rashchupkina ZP
    Klin Med (Mosk); 1982 Jan; 60(1):77-82. PubMed ID: 7078046
    [No Abstract]   [Full Text] [Related]  

  • 14. Dermal elastin and collagen in systemic sclerosis. Effect of D-penicillamine treatment.
    Pasquali Ronchetti I; Guerra D; Quaglino D; Vincenzi D; Manzini E; Canossi B; Manzini CU
    Clin Exp Rheumatol; 1989; 7(4):373-83. PubMed ID: 2591110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of systemic sclerosis.
    Medsger TA
    Rheum Dis Clin North Am; 1989 Aug; 15(3):513-31. PubMed ID: 2672135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis: analysis of a two-year, double-blind, randomized, controlled clinical trial.
    Clements PJ; Furst DE; Wong WK; Mayes M; White B; Wigley F; Weisman MH; Barr W; Moreland LW; Medsger TA; Steen V; Martin RW; Collier D; Weinstein A; Lally E; Varga J; Weiner S; Andrews B; Abeles M; Seibold JR
    Arthritis Rheum; 1999 Jun; 42(6):1194-203. PubMed ID: 10366112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in the growth and metabolism of cells cultured from normal, sclerotic and rheumatoid connective tissue brought about by D-penicillamine and by sodium salicylate.
    Priestley GC
    J Invest Dermatol; 1980 Jun; 74(6):413-7. PubMed ID: 6445922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased collagen accumulation in dermal fibroblast cultures from patients with progressive systemic sclerosis (scleroderma).
    Buckingham RB; Prince RK; Rodnan GP; Taylor F
    J Lab Clin Med; 1978 Jul; 92(1):5-21. PubMed ID: 351108
    [No Abstract]   [Full Text] [Related]  

  • 19. [D-penicillamine in the treatment of progressive systemic sclerosis].
    Marques Neto JF; Manzato LC; Samara AM
    AMB Rev Assoc Med Bras; 1980 Jun; 26(6):191-3. PubMed ID: 6970374
    [No Abstract]   [Full Text] [Related]  

  • 20. Skin collagen in patients with scleroderma: biosynthesis and maturation in vitro, and the effect of D-penicillamine.
    Uitto J; Helin P; Rasmussen O; Lorenzen I
    Ann Clin Res; 1970 Sep; 2(3):228-34. PubMed ID: 5473163
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.